Results 221 to 230 of about 352,666 (292)

Modulation of KATP channels by diazoxide preserves mitochondrial function and barrier integrity under staurosporine‐induced epithelial stress

British Journal of Pharmacology, EarlyView.
Background and Purpose Intestinal barrier dysfunction caused by mitochondrial stress, oxidative damage and apoptosis, are hallmarks of dysbiosis‐associated gastrointestinal (GI) disorders. Staurosporine causes downstream features of dysbiosis‐induced epithelial damage.
Fatima Maqoud, Eleonora Malerba, Simona Drago, Antonella Orlando, Domenica Mallardi, Nicoletta De Lucia, Marina Antonacci, Annamaria Di Turi, Domenico Tricarico, Francesco Russo   +9 more
wiley   +1 more source

Ferroptosis and Its Potential Role in the Physiopathology of Skeletal Muscle Atrophy. [PDF]

Int J Mol Sci
Sun CC, Xiao JL, Sun C, Tang CF.
europepmc   +1 more source

Circulating Musclin is associated with skeletal muscle function and subclinical cardiac dysfunction in patients with cancer

British Journal of Pharmacology, EarlyView.
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer, Daniel Finke, Sebastian Romann, Norbert Frey, Joerg Heineke, Lorenz H. Lehmann   +5 more
wiley   +1 more source

Skeletal Muscle Atrophy Induced by Dexamethasone Is Attenuated by Amino Acid Complex Supplementation in Rats. [PDF]

Life (Basel)
Lim SJ, Kim HJ, Kim H, Nam H, Nam KS, Kim I, Kang R, Hwang I, Kang JS.   +8 more
europepmc   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Biomarkers of Skeletal Muscle Atrophy Based on Atrogenes Evaluation: A Systematic Review and Meta-Analysis Study. [PDF]

Int J Mol Sci
Souza ALG, Alves ALR, Martinez CG, Sousa JC, Kurtenbach E.   +4 more
europepmc   +1 more source

Physiological and morphological impact of physical activity and nutritional interventions to offset disuse-induced skeletal muscle atrophy. [PDF]

Eur J Transl Myol
Arif I, Rasheed A, Nazeer S, Shahid F.
europepmc   +1 more source

Mitophagy is required to protect against excessive skeletal muscle atrophy following hindlimb immobilization. [PDF]

J Biomed Sci
Rahman FA, Graham MQ, Adam AM, Juracic ES, Tupling AR, Quadrilatero J.   +5 more
europepmc   +1 more source

Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved. [PDF]

Rev Endocr Metab Disord
Castillo ÍMP, Argilés JM, Rueda R, Ramírez M, Pedrosa JML.   +4 more
europepmc   +1 more source

Loss of popdc3 Impairs Mitochondrial Function and Causes Skeletal Muscle Atrophy and Reduced Swimming Ability in Zebrafish. [PDF]

J Cachexia Sarcopenia Muscle
Sun CC, Chen ZL, Yang D, Xiao JL, Chen XT, Peng XY, Wu XS, Tang CF.   +7 more
europepmc   +1 more source